Updated on 20 August 2026
Clinical Data Management and Biobanking Services
researcher at Jagiellonian University Medical College
Krakow, Poland
About
Cooperation in the management of clinical and research data, including access to clinical datasets and experimental research resources, as well as access to biological material collected and banked during clinical trials. The collaboration may also include expert consultation on biobanking strategies and procedures, as well as the preparation of cost estimates for biobanking services during the development and preparation of research project proposals.
Topic
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Similar opportunities
Project cooperation
Clinical trial support and Research Collaboration
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Natalia Wilczyńska-Zawal
researcher at Jagiellonian University Medical College
Krakow, Poland
Project cooperation
(CANCER-03) GMP manufacturing and first-in-human trial delivery for rare-cancer therapeutics
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Ilias Nikolinakos
EU Grants and Funding Coordinator at Elpen Pharmaceutical Co. Inc.
Athens, Greece
Project cooperation
Organ on chips, organoids and other NAMs for biomedical research
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Joude Cachoux
Business Development Manager, PharmD, MPH at Leitat Technological Center
Barcelona, Spain